Nuclera
Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.
About Nuclera
Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
Company Facts
- Headquarters
- Cambridge
- Operating Status
- active
- Funding Stage
- late_stage_venture
- Total Funding
- $157,807,647
- Last Funding Type
- series_c
- Last Funding Date
- 2026-01-13
- Website
- nuclera.com
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/nuclera-22733 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.